Loading viewer...
conference
Format: PDF conference
Provectus Biopharmaceuticals held an investor conference call on February 9, 2017, presenting company updates and strategic information. The presentation materials were filed with the SEC as part of the company's Form 8-K current report filing.
presentation
conference
27 Pages
Accelerate Diagnostics, Inc.
North Carolina Turnpike Authority Finance Committee Meeting July 2023
conferenceconference
58 Pages
North Carolina Turnpike Authority
American Academy of Actuaries Cyber 2024 NAIC Spring Meeting
conferenceconference
12 Pages
American Academy of Actuaries
Hanmi Financial Corporation 2017 West Coast Conference
conferenceconference
17 Pages
Hanmi Financial Corporation
Packable Holdings Analyst Day 2021
conferenceconference
96 Pages
Packable Holdings, LLC
